Photodynamic therapy of lower genital tract neoplasia. 2002

Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson

UI MeSH Term Description Entries
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D005260 Female Females
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000622 Aminolevulinic Acid A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. 5-Amino Levulinic Acid,5-Aminolaevulinate,5-Aminolevulinate,Aminolevulinic Acid Hydrochloride,Delta-Aminolevulinic Acid,Levulan,5 Amino Levulinic Acid,5 Aminolaevulinate,5 Aminolevulinate,Acid Hydrochloride, Aminolevulinic,Acid, 5-Amino Levulinic,Acid, Aminolevulinic,Acid, Delta-Aminolevulinic,Delta Aminolevulinic Acid,Hydrochloride, Aminolevulinic Acid,Levulinic Acid, 5-Amino
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing

Related Publications

Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
March 2010, Photodiagnosis and photodynamic therapy,
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
August 1990, Seminars in oncology nursing,
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
January 1991, Antibiotics and chemotherapy,
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
December 1998, Oncology (Williston Park, N.Y.),
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
January 1993, Journal of gynecologic surgery,
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
January 1992, Journal de gynecologie, obstetrique et biologie de la reproduction,
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
January 1985, Acta cytologica,
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
October 2001, Best practice & research. Clinical obstetrics & gynaecology,
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
June 2002, Lancet (London, England),
Pierre Martin-Hirsch, and Henry C Kitchener, and Ian N Hampson
May 1995, The Nurse practitioner,
Copied contents to your clipboard!